Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX<sup>®</sup>. Executive Summary of the 2010 Position Development Conference on Interpretation and Use of FRAX<sup>®</sup>in Clinical Practice
Hans DB., Kanis JA., Baim S., Bilezikian JP., Binkley N., Cauley JA., Compston JE., Cooper C., Dawson-Hughes B., El-Hajj Fuleihan G., Leslie WD., Lewiecki EM., Luckey MM., McCloskey EV., Papapoulos SE., Poiana C., Rizzoli R.
The International Society for Clinical Densitometry (ISCD) and the International Osteoporosis Foundation (IOF) convened the FRAX ® Position Development Conference (PDC) in Bucharest, Romania, on November 14, 2010, following a two-day joint meeting of the ISCD and IOF on the "Interpretation and Use of FRAX ® in Clinical Practice." These three days of critical discussion and debate, led by a panel of international experts from the ISCD, IOF and dedicated task forces, have clarified a number of important issues pertaining to the interpretation and implementation of FRAX ® in clinical practice. The Official Positions resulting from the PDC are intended to enhance the quality and clinical utility of fracture risk assessment worldwide. Since the field of skeletal assessment is still evolving rapidly, some clinically important issues addressed at the PDCs are not associated with robust medical evidence. Accordingly, some Official Positions are based largely on expert opinion. Despite limitations inherent in such a process, the ISCD and IOF believe it is important to provide clinicians and technologists with the best distillation of current knowledge in the discipline of bone densitometry and provide an important focus for the scientific community to consider. This report describes the methodology and results of the ISCD-IOF PDC dedicated to FRAX ® . © 2011 The International Society for Clinical Densitometry.